Peripheral neural cell sensitivity to mTHPC-mediated photodynamic therapy in a 3D in vitro model

Por Wright, K E, Liniker, E, Loizidou, M, Moore, C, MacRobert, A J, Phillips, J B
Publicado em 2009

Treatment costs associated with interventional cancer clinical trials conducted at a single UK institution over 2 years (2009–2010)

Por Liniker, E, Harrison, M, Weaver, J M J, Agrawal, N, Chhabra, A, Kingshott, V, Bailey, S, Eisen, T G G, Corrie, P G
Publicado em 2013

Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma

Por Liniker, E., Menzies, A. M., Kong, B. Y., Cooper, A., Ramanujam, S., Lo, S., Kefford, R. F., Fogarty, G. B., Guminski, A., Wang, T. W., Carlino, M. S., Hong, A., Long, G. V.
Publicado no Oncoimmunology (2016)

Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy

Por Bowyer, S, Prithviraj, P, Lorigan, P, Larkin, J, McArthur, G, Atkinson, V, Millward, M, Khou, M, Diem, S, Ramanujam, S, Kong, B, Liniker, E, Guminski, A, Parente, P, Andrews, M C, Parakh, S, Cebon, J, Long, G V, Carlino, M S, Klein, O
Publicado no Br J Cancer (2016)